Brian Rayner

8.0k citations
146 papers · 3.5k · 2 hit papers · h-index 31

Impact in

  • Nephrology top 1%
    • Chronic Kidney Disease and Diabetes
    • Dialysis and Renal Disease Management
    • Renal Diseases and Glomerulopathies
    • Diabetes Treatment and Management
    • Hormonal Regulation and Hypertension

Papers in

Brian Rayner

136 papers receiving 3.4k citations

Brian Rayner's Hit Papers

Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial 2018 · 482 citations
4820+3+6Years since publication100200300400

Peers

Brian Rayner
Comparison fields: 5 of 131
  • Nephrology 546
  • Endocrinology, Diabetes and Metabolism 887
  • Family Practice 70
  • Cardiology and Cardiovascular Medicine 723
  • Emergency Medicine 147
Replace Min Jun with:
Min Jun Australia
Laurent Billot Australia
Ingrid Os Norway
Shang‐Jyh Hwang Taiwan
Borislava Mihaylova United Kingdom
J. Michael Paterson Canada
Walter Palmas United States
Richard Lewanczuk Canada
Glen C. Bennett United States
Heikki Miettinen Finland
Brian Rayner relative to Min Jun Australia Min Jun's profile →
Citations per field
00.5×1.5×2.4×
Min Jun · 1×
Citations per year

Countries citing papers authored by Brian Rayner

Since Specialization
Citations

This map shows the geographic impact of Brian Rayner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Rayner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Rayner more than expected).

Fields of papers citing papers by Brian Rayner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Rayner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Rayner. The network helps show where Brian Rayner may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian Rayner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian Rayner Line = papers co-authored together Brian Rayner links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 146 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Hit paper breakdown →
2018482
2
Mobile Phone Text Messages to Support Treatment Adherence in Adults With High Blood Pressure (SMS-Text Adherence Support [StAR])
Hit paper breakdown →
2016235
3 2005127
4 2018121
5 2014121
6 2013115
7
South African hypertension guideline 2006.
2006105
8 201095
9 201889
10
The aldosterone/renin ratio as a screening test for primary aldosteronism.
200079
11 201173
12 201469
13
Differences in hypertension between blacks and whites: an overview.
200867
14 200366
15 201159
16 200455
17 199254
18
Screening for primary aldosteronism--normal ranges for aldosterone and renin in three South African population groups.
200152
19 201749
20 200645

About Brian Rayner

Brian Rayner is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Nephrology, Public Health, Environmental and Occupational Health and Molecular Biology, having authored 146 papers that have together received 3.5k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (40 papers), Hormonal Regulation and Hypertension (19 papers), Dialysis and Renal Disease Management (10 papers), Sodium Intake and Health (7 papers), Ion Transport and Channel Regulation (7 papers), Diabetes Treatment and Management (7 papers), Chronic Kidney Disease and Diabetes (6 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Nephrology (546 citations), Endocrinology, Diabetes and Metabolism (887 citations), Family Practice (70 citations), Cardiology and Cardiovascular Medicine (723 citations) and Emergency Medicine (147 citations). Brian Rayner has collaborated with scholars based in South Africa, United States and United Kingdom. Frequent co-authors include Mark Lakshmanan, Fady T. Botros, J. David Spence, Alan G. Zimmermann, Erika Jones, Robert S. Busch, Y.K. Seedat, Lionel H. Opie, Okechukwu S. Ogah and Y Veriava. Their work appears in journals such as PLoS ONE, American Journal of Hypertension, Clinical Nephrology, Journal of Hypertension and Peritoneal Dialysis International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact